According to filings with the U.S. Securities and Exchange Commission, Lifeward Ltd. is raising up to $11,160,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Lifeward Ltd.
Lifeward Ltd. is a medical technology company that designs, develops, and commercializes proven solutions that fundamentally improve quality of life by facilitating improved function and health in rehabilitation and daily life. Positioned as a leading source of innovations for healthcare professionals, Lifeward focuses on delivering life-changing results for people with physical limitation or disability and helping individuals achieve outcomes they never thought possible. The companys portfolio spans the continuum of care, providing functional and health benefits in clinical settings as well as in the home and community, and is aimed at supporting clinicians and patients at every step of rehabilitation, recovery, and the pursuit of lifes passions despite physical challenges. Through its global presence, including Lifeward Ltd. in Yokneam Ilit, Israel, Lifeward backs its solutions with dedicated media and investor relations operated out of Lifeward Ltd., underscoring its role as a central corporate entity within the broader Lifeward organization. Overall, Lifeward Ltd. serves as the core of a mission-driven company that seeks to redefine what is possible in overcoming physical limitations, combining advanced medical technologies with comprehensive support to elevate standards of care in rehabilitation and daily living.

To learn more, visit https://www.golifeward.com/
LinkedIn: https://www.linkedin.com/company/golifeward

Contact:
Willliam Grant, President and Chief Executive Officer

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.